Type I Interferon Programs Innate Myeloid Dynamics and Gene Expression in the Virally Infected Nervous System

PLoS Pathogens

Volumn 9, Issue 5, 2013, Pages

  Nayak, Debasis ^a   Johnson, Kory R ^a   Heydari, Sara ^a   Roth, Theodore L ^a   Zinselmeyer, Bernd H ^a   McGavern, Dorian B ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DNA MICROARRAY; EPIFLUORESCENCE MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MONONUCLEAR CELL; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ANIMALS; GENE EXPRESSION REGULATION; INTERFERON TYPE I; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, KNOCKOUT; MYELOID CELLS; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 84878502792     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003395     Document Type: Article

References (59)

1. Ransohoff RM, Engelhardt B, (2012) The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12: 623-635.
2. Bechmann I, Galea I, Perry VH, (2007) What is the blood-brain barrier (not)? Trends Immunol 28: 5-11.
3. McGavern DB, Kang SS, (2011) Illuminating viral infections in the nervous system. Nat Rev Immunol 11: 318-329.
4. Matzinger P, (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991-1045.
5. Medzhitov R, Janeway C Jr, (2000) Innate immune recognition: mechanisms and pathways. Immunol Rev 173: 89-97.
6. Medawar PB, (1948) Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29: 58-69.
7. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A, (2011) Physiology of microglia. Physiol Rev 91: 461-553.
8. Nimmerjahn A, Kirchhoff F, Helmchen F, (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318.
9. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, et al. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8: 752-758.
10. Hickey WF, Kimura H, (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290-292.
11. Bulloch K, Miller MM, Gal-Toth J, Milner TA, Gottfried-Blackmore A, et al. (2008) CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J Comp Neurol 508: 687-710.
12. Anandasabapathy N, Victora GD, Meredith M, Feder R, Dong B, et al. (2011) Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J Exp Med 208: 1695-1705.
13. Nayak D, Zinselmeyer BH, Corps KN, McGavern DB, (2012) In vivo dynamics of innate immune sentinels in the CNS. Intravital 1: 95-106.
14. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, et al. (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845.
15. Sadler AJ, Williams BR, (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
16. Trinchieri G, (2010) Type I interferon: friend or foe? J Exp Med 207: 2053-2063.
17. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
18. Liu SY, Sanchez DJ, Aliyari R, Lu S, Cheng G, (2012) Systematic identification of type I and type II interferon-induced antiviral factors. Proc Natl Acad Sci U S A 109: 4239-4244.
19. Paul S, Ricour C, Sommereyns C, Sorgeloos F, Michiels T, (2007) Type I interferon response in the central nervous system. Biochimie 89: 770-778.
20. Haller O, Kochs G, Weber F, (2006) The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344: 119-130.
21. Garcia-Sastre A, Biron CA, (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312: 879-882.
22. Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA, et al. (2010) Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J Virol 84: 9452-9462.
23. Rubartelli A, Lotze MT, (2007) Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 28: 429-436.
24. Kim JV, Kang SS, Dustin ML, McGavern DB, (2009) Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457: 191-195.
25. McGavern DB, Truong P, (2004) Rebuilding an immune-mediated central nervous system disease: weighing the pathogenicity of antigen-specific versus bystander T cells. J Immunol 173: 4779-4790.
26. Truong P, McGavern DB, (2008) A novel virus carrier state to evaluate immunotherapeutic regimens: regulatory T cells modulate the pathogenicity of antiviral memory cells. J Immunol 181: 1161-1169.
27. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
28. Clarke SR, Barnden M, Kurts C, Carbone FR, Miller JF, et al. (2000) Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol 78: 110-117.
29. McCausland MM, Crotty S, (2008) Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo. J Virol Methods 147: 167-176.
30. Borrow P, Oldstone MB, (1992) Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus. J Virol 66: 7270-7281.
31. Parekh BS, Buchmeier MJ, (1986) Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology 153: 168-178.
32. Sullivan BM, Emonet SF, Welch MJ, Lee AM, Campbell KP, et al. (2011) Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc Natl Acad Sci U S A 108: 2969-2974.
33. Lee KJ, Perez M, Pinschewer DD, de la Torre JC, (2002) Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol 76: 6393-6397.
34. Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, et al. (2000) Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med 192: 1249-1260.
35. Herz J, Zinselmeyer BH, McGavern DB, (2012) Two-photon imaging of microbial immunity in living tissues. Microsc Microanal 18: 730-741.
36. Yang G, Pan F, Parkhurst CN, Grutzendler J, Gan WB, (2010) Thinned-skull cranial window technique for long-term imaging of the cortex in live mice. Nat Protoc 5: 201-208.
37. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, et al. (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20: 4106-4114.
38. Deonarain R, Alcami A, Alexiou M, Dallman MJ, Gewert DR, et al. (2000) Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol 74: 3404-3409.
39. Martínez-Sobrido L, Zúñiga EI, Rosario D, García-Sastre A, de la Torre JC, (2006) Inhibition of the Type I Interferon Response by the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus. J Virol 80: 9192-9199.
40. Martínez-Sobrido L, Emonet S, Giannakas P, Cubitt B, García-Sastre A, et al. (2009) Identification of Amino Acid Residues Critical for the Anti-Interferon Activity of the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus. J Virol 83: 11330-11340.
41. Pythoud C, Rodrigo WW, Pasqual G, Rothenberger S, Martinez-Sobrido L, et al. (2012) Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon. J Virol 86: 7728-7738.
42. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
43. Wang X, Hinson ER, Cresswell P, (2007) The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2: 96-105.
44. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7: e1002337.
45. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
46. Carter CC, Gorbacheva VY, Vestal DJ, (2005) Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Arch Virol 150: 1213-1220.
47. Welsh RM, Burner PA, Holland JJ, Oldstone MB, Thompson HA, et al. (1975) A comparison of biochemical and biological properties of standard and defective lymphocytic choriomeningitis virus. Bull World Health Organ 52: 403-408.
48. Popescu M, Lehmann-Grube F, (1977) Defective interfering particles in mice infected with lymphocytic choriomeningitis virus. Virology 77: 78-83.
49. Oldstone MB, Buchmeier MJ, (1982) Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 300: 360-362.
50. Richards KH, Macdonald A, (2011) Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production. Microbes Infect 13: 291-302.
51. Cui J, Zhu L, Xia X, Wang HY, Legras X, et al. (2010) NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141: 483-496.
52. Higgs R, Ni Gabhann J, Ben Larbi N, Breen EP, Fitzgerald KA, et al. (2008) The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J Immunol 181: 1780-1786.
53. Saron MF, Riviere Y, Hovanessian AG, Guillon JC, (1982) Chronic production of interferon in carrier mice congenitally infected with lymphocytic choriomeningitis virus. Virology 117: 253-256.
54. Kunz S, Rojek JM, Roberts AJ, McGavern DB, Oldstone MB, et al. (2006) Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus. J Virol 80: 9082-9092.
55. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, et al. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670.
56. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
57. Sharma S, DeOliveira RB, Kalantari P, Parroche P, Goutagny N, et al. (2011) Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 35: 194-207.
58. Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T, et al. (2010) Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 465: 1079-1083.
59. Xu HT, Pan F, Yang G, Gan WB, (2007) Choice of cranial window type for in vivo imaging affects dendritic spine turnover in the cortex. Nat Neurosci 10: 549-551.